<?xml version="1.0" encoding="UTF-8"?>

<PlanDefinition xmlns="http://hl7.org/fhir">
  <id value="AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan"/>
  <meta>
    <profile value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: PlanDefinition AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan</b></p><a name="AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan"> </a><a name="hcAntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan"> </a><a name="AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan-en-US"> </a><p><b>url</b>: <a href="PlanDefinition-AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan.html">PlanDefinition Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</a></p><p><b>version</b>: 0.1</p><p><b>name</b>: AntithromboticProphylaxisWithFondaparinux</p><p><b>title</b>: Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type eca-rule}">ECA Rule</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>subject</b>: <a href="EvidenceVariable-PopHospitalisedCOVID19PatientsWithContraIndications.html">Population: Hospitalised COVID-19 patients with existing contraindications to LWMH</a></p><p><b>date</b>: 2022-04-27</p><p><b>publisher</b>: NUM CODEX+ CELIDA</p><p><b>description</b>: </p><div><p>Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</p>
</div><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-AntithromboticProphylaxisFondaparinuxSubcutaneous.html">Antithrombotic prophylaxis with Fondaparinux</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 432102000}">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href="ActivityDefinition-NoTherapeuticAnticoagulationFondaparinux.html">NO Therapeutic Anticoagulation Treatment with Fondaparinux</a></p></blockquote></div>
  </text>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel">
    <valueCode value="structured"/>
  </extension>
  <extension url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-partOf">
    <valueCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/prophylactic-anticoagulation"/>
  </extension>
  <extension url="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method">
    <extension url="method">
      <valueCodeableConcept>
        <coding>
          <system value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method"/>
          <code value="all"/>
        </coding>
      </valueCodeableConcept>
    </extension>
  </extension>
  <url value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/antithrombotic-prophylaxis-fondaparinux"/>
  <version value="0.1"/>
  <name value="AntithromboticProphylaxisWithFondaparinux"/>
  <title value="Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
      <code value="eca-rule"/>
    </coding>
  </type>
  <status value="active"/>
  <experimental value="true"/>
  <subjectCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/population/hospitalised-covid19-patients-with-LMWH-contraindications"/>
  <date value="2022-04-27"/>
  <publisher value="NUM CODEX+ CELIDA"/>
  <description value="Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients"/>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/antithrombotic-prophylaxis-fondaparinux-administration"/>
  </action>
  <action>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="432102000"/>
        <display value="Administration of substance (procedure)"/>
      </coding>
    </code>
    <definitionCanonical value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/no-therapeutic-anticoagulant-fondaparinux-administration"/>
  </action>
</PlanDefinition>